Cargando…
Targeting NSP16 Methyltransferase for the Broad-Spectrum Clinical Management of Coronaviruses: Managing the Next Pandemic
With the approval and distribution of demonstrably safe COVID-19 vaccines bearing exceptionally high efficacy profiles, it may be tempting to envision a return to “normal” in the coming months. However, if there is one lesson to be learned from the ongoing pandemic, it is that, in a world of evolvin...
Autores principales: | Alshiraihi, Ilham M., Klein, Gerald L., Brown, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930934/ https://www.ncbi.nlm.nih.gov/pubmed/33535388 http://dx.doi.org/10.3390/diseases9010012 |
Ejemplares similares
-
Epigenetic Factors of Disease
por: Alshiraihi, Ilham, et al.
Publicado: (2019) -
Crystal Structure and Functional Analysis of the SARS-Coronavirus RNA Cap 2′-O-Methyltransferase nsp10/nsp16 Complex
por: Decroly, Etienne, et al.
Publicado: (2011) -
Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase
por: Benoni, Roberto, et al.
Publicado: (2021) -
Clinical Sciences—Leading the Way in Competency-Based Biomedical Education
por: Brown, Mark A., et al.
Publicado: (2020) -
Structural Analysis of SMYD3 Lysine Methyltransferase for the Development of Competitive and Specific Enzyme Inhibitors
por: Jarrell, Dillon K., et al.
Publicado: (2021)